Twentyeight-Seven Therapeutics nabs $15 mln
Sofinnova Partners has led a $15 million round for Twentyeight-Seven Therapeutics Inc. Also, Osage University Partner participated in the financing. Based in Watertown, Massachusetts, Twentyeight-Seven Therapeutics is a biotech company focused on the modulation of RNA to treat cancer and other human diseases.
9 May 2019•1 min read
